Orano Med: Funding, Investors & Team (Oct 2026)
Orano Med is focused on creating advanced cancer treatments that target specific areas. The company specializes in high-quality chelating agents and offers a variety of products and services. Their strategy involves building a strong lineup of therapies and maintaining a steady supply of isotopes.
Orano Med has raised $347M across 1 funding round on record, the most recent an undisclosed round of $347M announced in Oct 2025.
That round is above the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Orano Med Company Profile and Key Stats
Latest funding round on record: Oct 2025.
Orano Med Funding Rounds
Orano Med Founders and Leadership Team
No contact details are on record for this team yet.
Orano Med Funding Compared to Other Biotechnology Startups
Orano Med's latest round of $347M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Orano Med in Biotechnology and Plano
Companies Similar to Orano Med
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
Orano Med Funding FAQs
What does Orano Med do?
Orano Med is focused on creating advanced cancer treatments that target specific areas. The company specializes in high-quality chelating agents and offers a variety of products and services. Their strategy involves building a strong lineup of therapies and maintaining a steady supply of isotopes.
How much funding has Orano Med raised?
Orano Med has raised $347M across 1 round on record. The most recent is an undisclosed round of $347M announced in Oct 2025.
When did Orano Med last raise funding?
Orano Med's most recent funding round on record is an undisclosed round of $347M, announced in Oct 2025.
Who founded Orano Med?
FundedIQ lists Julien Dodet (Founder) at Orano Med.
Where is Orano Med headquartered?
Orano Med is based in Plano, Texas, United States.
How many employees does Orano Med have?
Orano Med is in the 101-250 employee band.
How does Orano Med's funding compare to other Biotechnology startups?
Orano Med's latest round of $347M is above the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Orano Med Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Orano Med is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.